The recent portfolio rebalance increased FDL's risk and volatility, with 55% concentration in its top 10 holdings. Read why I ...

The system for compensating people injured by vaccines needs significant reform. But the health secretary could alter it in ...

Women with advanced form womb cancer have been given fresh hope after a new treatment was given the green light for ...

Merck is an industry giant that has proved time and again it can innovate for the future. Ventas has positioned itself to ...

Novo Nordisk, GSK and others need to replenish their pipelines to replace drugs coming off patent. In the past, buying a promising biotech required paying a 100% premium. But high interest rates and ...

China’s drugmakers are racing to roll out cheaper or more innovative alternatives. Read more at straitstimes.com. Read more ...

An updated guideline on pharmacotherapy of obesity management in adults includes six new and seven revised recommendations, ...

Pharma firms are pouncing on opportunity as patents on world’s second-bestselling drug, which goes by brand names Ozempic and ...

The number of significant shareholder protests has more than doubled so far this year compared with a year ago, with 11 FTSE ...

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, ...

WAYNE, PA — Sam Brown Healthcare Communications, a Blue Matter Company, has appointed Michael Heinley as its new Managing ...

Any of them would work well enough if you don't actually need the income right now, but brewing changes make one more of a ...